Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  INDONESIA STOCK EXCHANGE  >  Kalbe Farma Tbk PT    KLBF   ID1000125107

KALBE FARMA TBK PT

(KLBF)
  Report
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in B IDR Estimates in B IDR
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 19 367 20 199 21 087 22 845 24 511 26 449
EBITDA 3 497 3 600 3 688 4 021 4 285 4 627
Operating profit (EBIT) 3 100 3 197 3 262 3 525 3 757 4 064
Pre-Tax Profit (EBT) 3 091 3 234 3 255 3 566 3 792 4 123
Net income 2 300 2 381 2 422 2 665 2 832 3 059
P/E ratio - - - 24,5x 23,0x 21,2x
EPS ( IDR ) 49,1 51,3 52,4 56,8 60,5 65,5
Dividend per Share ( IDR ) 19,0 22,0 - 26,5 28,0 30,6
Yield - - - 1,90% 2,01% 2,20%
Reference price ( IDR ) - - - 1 390,000 1 390,000 1 390,000
Announcement Date 02/20/2017
02:21pm
02/13/2018
11:59pm
02/14/2019
10:13am
- - -
Finances - Leverage
Actuals in B IDR Estimates in B IDR
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - - -
Finance 2 804 2 658 2 975 2 807 2 682 2 801
Operating income (EBITDA) 3 497 3 600 3 688 4 021 4 285 4 627
Leverage
(Debt/EBITDA)
- - - - - -
Capital Expenditure 1 039 1 164 1 355 1 451 1 469 1 527
Free Cash Flow (FCF) 1 120 782 844 481 1 463 449 821 004 842 969 1 230 607
Book Value Per Share (BVPS) ( IDR ) 254 283 312 344 375 410
Cash Flow per Share ( IDR ) 46,1 42,8 59,1 61,3 59,3 67,0
Announcement Date 02/20/2017
02:21pm
02/13/2018
11:59pm
02/14/2019
10:13am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 65 156 420 M IDR -
Entreprise Value (EV) 65 153 613 M IDR 65 153 738 M IDR
Valuation 2019e 2020e
P/E ratio (Price / EPS) 24,5x 23,0x
Capitalization / Revenue 2 852x 2 658x
EV / Revenue 2 852x 2 658x
EV / EBITDA 16 204x 15 206x
Yield (DPS / Price) 1,90% 2,01%
Price to book (Price / BVPS) 4,04x 3,71x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 15,4% 15,3%
Operating Leverage (Delta EBIT / Delta Sales) 0,97x 0,90x
Net Margin (Net Profit / Revenue) 11,7% 11,6%
ROA (Net Profit / Asset) 13,6% 13,3%
ROE (Net Profit / Equities) 17,1% 16,5%
Rate of Dividend 46,6% 46,3%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   6,35% 5,99%
Cash Flow / Sales 12,6% 11,3%
Capital Intensity (Assets / Sales) 0,86x 0,87x
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend